A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. - Handgretinger,R.; Anderson,K.; Lang,P.; Dopfer,R.; Klingebiel,T.; Schrappe,M.; Reuland,P.; Gillies,S.D.; Reisfeld,R.A.; Niethammer,D. (Eur J Cancer, 1995)